APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Ceftazidime

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Ceftazidime Market Analysis and Forecast 2026-2032

Report ID 173976060222 December 2025198 pages

Choose your research edition.

Industry ResearchCeftazidime Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Ceftazidime Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Ceftazidime Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ceftazidime Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Ceftazidime Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Ceftazidime market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Ceftazidime is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Ceftazidime is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Ceftazidime is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Ceftazidime is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Ceftazidime include Fujian Fukang Pharmaceutical, NCPC, United Laboratories, Sinopharm Sandwich, Shanghai Pharmaceutical, Union Chempharma and Youcare Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Ceftazidime, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Ceftazidime, also provides the sales of main regions and countries. Of the upcoming market potential for Ceftazidime, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Ceftazidime sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Ceftazidime market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Ceftazidime sales, projected growth trends, production technology, application and end-user industry.

Ceftazidime Segment by Company

Fujian Fukang Pharmaceutical

NCPC

United Laboratories

Sinopharm Sandwich

Shanghai Pharmaceutical

Union Chempharma

Youcare Pharmaceutical

Ceftazidime Segment by Type

Powder Injection

Injection

Ceftazidime Segment by Application

Respiratory Infections

Urinary Infections

Skin Infections

Other

Ceftazidime Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ceftazidime market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ceftazidime and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ceftazidime.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Ceftazidime in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Ceftazidime manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ceftazidime sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ceftazidime Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Powder Injection Major Manufacturers Table 3. Injection Major Manufacturers Table 4. Global Ceftazidime Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Respiratory Infections Major Manufacturers Table 6. Urinary Infections Major Manufacturers Table 7. Skin Infections Major Manufacturers Table 8. Other Major Manufacturers Table 9. Ceftazidime Industry Trends Table 10. Ceftazidime Industry Drivers Table 11. Ceftazidime Industry Opportunities and Challenges Table 12. Ceftazidime Industry Restraints Table 13. Global Ceftazidime Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Ceftazidime Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Ceftazidime Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Ceftazidime Revenue Market Share by Region (2021-2026) Table 17. Global Ceftazidime Revenue Market Share by Region (2027-2032) Table 18. Global Ceftazidime Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (tons) Table 19. Global Ceftazidime Sales by Region (2021-2026) & (tons) Table 20. Global Ceftazidime Sales by Region (2027-2032) & (tons) Table 21. Global Ceftazidime Sales Market Share by Region (2021-2026) Table 22. Global Ceftazidime Sales Market Share by Region (2027-2032) Table 23. Global Ceftazidime Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Ceftazidime Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Ceftazidime Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Ceftazidime Sales Market Share by Manufacturers (2021-2026) Table 27. Global Ceftazidime Sales Price (US$/kg) of Manufacturers (2021-2026) Table 28. Global Ceftazidime Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Ceftazidime Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Ceftazidime Manufacturers, Product Type & Application Table 31. Global Ceftazidime Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Ceftazidime by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Ceftazidime Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Ceftazidime Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Ceftazidime Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Ceftazidime Revenue Market Share by Type (2021-2026) Table 38. Global Ceftazidime Revenue Market Share by Type (2027-2032) Table 39. Global Ceftazidime Sales by Type 2021 VS 2025 VS 2032 (tons) Table 40. Global Ceftazidime Sales by Type (2021-2026) & (tons) Table 41. Global Ceftazidime Sales by Type (2027-2032) & (tons) Table 42. Global Ceftazidime Sales Market Share by Type (2021-2026) Table 43. Global Ceftazidime Sales Market Share by Type (2027-2032) Table 44. Global Ceftazidime Price by Type (2021-2026) & (US$/kg) Table 45. Global Ceftazidime Price by Type (2027-2032) & (US$/kg) Table 46. Global Ceftazidime Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Ceftazidime Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Ceftazidime Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Ceftazidime Revenue Market Share by Application (2021-2026) Table 50. Global Ceftazidime Revenue Market Share by Application (2027-2032) Table 51. Global Ceftazidime Sales by Application 2021 VS 2025 VS 2032 (tons) Table 52. Global Ceftazidime Sales by Application (2021-2026) & (tons) Table 53. Global Ceftazidime Sales by Application (2027-2032) & (tons) Table 54. Global Ceftazidime Sales Market Share by Application (2021-2026) Table 55. Global Ceftazidime Sales Market Share by Application (2027-2032) Table 56. Global Ceftazidime Price by Application (2021-2026) & (US$/kg) Table 57. Global Ceftazidime Price by Application (2027-2032) & (US$/kg) Table 58. Fujian Fukang Pharmaceutical Company Information Table 59. Fujian Fukang Pharmaceutical Business Overview Table 60. Fujian Fukang Pharmaceutical Ceftazidime Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 61. Fujian Fukang Pharmaceutical Ceftazidime Product Portfolio Table 62. Fujian Fukang Pharmaceutical Recent Development Table 63. NCPC Company Information Table 64. NCPC Business Overview Table 65. NCPC Ceftazidime Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 66. NCPC Ceftazidime Product Portfolio Table 67. NCPC Recent Development Table 68. United Laboratories Company Information Table 69. United Laboratories Business Overview Table 70. United Laboratories Ceftazidime Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 71. United Laboratories Ceftazidime Product Portfolio Table 72. United Laboratories Recent Development Table 73. Sinopharm Sandwich Company Information Table 74. Sinopharm Sandwich Business Overview Table 75. Sinopharm Sandwich Ceftazidime Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 76. Sinopharm Sandwich Ceftazidime Product Portfolio Table 77. Sinopharm Sandwich Recent Development Table 78. Shanghai Pharmaceutical Company Information Table 79. Shanghai Pharmaceutical Business Overview Table 80. Shanghai Pharmaceutical Ceftazidime Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 81. Shanghai Pharmaceutical Ceftazidime Product Portfolio Table 82. Shanghai Pharmaceutical Recent Development Table 83. Union Chempharma Company Information Table 84. Union Chempharma Business Overview Table 85. Union Chempharma Ceftazidime Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 86. Union Chempharma Ceftazidime Product Portfolio Table 87. Union Chempharma Recent Development Table 88. Youcare Pharmaceutical Company Information Table 89. Youcare Pharmaceutical Business Overview Table 90. Youcare Pharmaceutical Ceftazidime Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 91. Youcare Pharmaceutical Ceftazidime Product Portfolio Table 92. Youcare Pharmaceutical Recent Development Table 93. North America Ceftazidime Revenue by Type (2021-2026) & (US$ Million) Table 94. North America Ceftazidime Revenue by Type (2027-2032) & (US$ Million) Table 95. North America Ceftazidime Sales by Type (2021-2026) & (tons) Table 96. North America Ceftazidime Sales by Type (2027-2032) & (tons) Table 97. North America Ceftazidime Sales Price by Type (2021-2026) & (US$/kg) Table 98. North America Ceftazidime Sales Price by Type (2027-2032) & (US$/kg) Table 99. North America Ceftazidime Revenue by Application (2021-2026) & (US$ Million) Table 100. North America Ceftazidime Revenue by Application (2027-2032) & (US$ Million) Table 101. North America Ceftazidime Sales by Application (2021-2026) & (tons) Table 102. North America Ceftazidime Sales by Application (2027-2032) & (tons) Table 103. North America Ceftazidime Sales Price by Application (2021-2026) & (US$/kg) Table 104. North America Ceftazidime Sales Price by Application (2027-2032) & (US$/kg) Table 105. North America Ceftazidime Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America Ceftazidime Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 107. North America Ceftazidime Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 108. North America Ceftazidime Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 109. North America Ceftazidime Sales by Country (2021-2026) & (tons) Table 110. North America Ceftazidime Sales by Country (2027-2032) & (tons) Table 111. North America Ceftazidime Sales Price by Country (2021-2026) & (US$/kg) Table 112. North America Ceftazidime Sales Price by Country (2027-2032) & (US$/kg) Table 113. United States Ceftazidime Revenue (2021-2032) & (US$ Million) Table 114. Canada Ceftazidime Revenue (2021-2032) & (US$ Million) Table 115. Mexico Ceftazidime Revenue (2021-2032) & (US$ Million) Table 116. Europe Ceftazidime Revenue by Type (2021-2026) & (US$ Million) Table 117. Europe Ceftazidime Revenue by Type (2027-2032) & (US$ Million) Table 118. Europe Ceftazidime Sales by Type (2021-2026) & (tons) Table 119. Europe Ceftazidime Sales by Type (2027-2032) & (tons) Table 120. Europe Ceftazidime Sales Price by Type (2021-2026) & (US$/kg) Table 121. Europe Ceftazidime Sales Price by Type (2027-2032) & (US$/kg) Table 122. Europe Ceftazidime Revenue by Application (2021-2026) & (US$ Million) Table 123. Europe Ceftazidime Revenue by Application (2027-2032) & (US$ Million) Table 124. Europe Ceftazidime Sales by Application (2021-2026) & (tons) Table 125. Europe Ceftazidime Sales by Application (2027-2032) & (tons) Table 126. Europe Ceftazidime Sales Price by Application (2021-2026) & (US$/kg) Table 127. Europe Ceftazidime Sales Price by Application (2027-2032) & (US$/kg) Table 128. Europe Ceftazidime Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Europe Ceftazidime Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 130. Europe Ceftazidime Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 131. Europe Ceftazidime Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 132. Europe Ceftazidime Sales by Country (2021-2026) & (tons) Table 133. Europe Ceftazidime Sales by Country (2027-2032) & (tons) Table 134. Europe Ceftazidime Sales Price by Country (2021-2026) & (US$/kg) Table 135. Europe Ceftazidime Sales Price by Country (2027-2032) & (US$/kg) Table 136. Germany Ceftazidime Revenue (2021-2032) & (US$ Million) Table 137. France Ceftazidime Revenue (2021-2032) & (US$ Million) Table 138. U.K. Ceftazidime Revenue (2021-2032) & (US$ Million) Table 139. Italy Ceftazidime Revenue (2021-2032) & (US$ Million) Table 140. Russia Ceftazidime Revenue (2021-2032) & (US$ Million) Table 141. Spain Ceftazidime Revenue (2021-2032) & (US$ Million) Table 142. Netherlands Ceftazidime Revenue (2021-2032) & (US$ Million) Table 143. Switzerland Ceftazidime Revenue (2021-2032) & (US$ Million) Table 144. Sweden Ceftazidime Revenue (2021-2032) & (US$ Million) Table 145. Poland Ceftazidime Revenue (2021-2032) & (US$ Million) Table 146. China Ceftazidime Revenue by Type (2021-2026) & (US$ Million) Table 147. China Ceftazidime Revenue by Type (2027-2032) & (US$ Million) Table 148. China Ceftazidime Sales by Type (2021-2026) & (tons) Table 149. China Ceftazidime Sales by Type (2027-2032) & (tons) Table 150. China Ceftazidime Sales Price by Type (2021-2026) & (US$/kg) Table 151. China Ceftazidime Sales Price by Type (2027-2032) & (US$/kg) Table 152. China Ceftazidime Revenue by Application (2021-2026) & (US$ Million) Table 153. China Ceftazidime Revenue by Application (2027-2032) & (US$ Million) Table 154. China Ceftazidime Sales by Application (2021-2026) & (tons) Table 155. China Ceftazidime Sales by Application (2027-2032) & (tons) Table 156. China Ceftazidime Sales Price by Application (2021-2026) & (US$/kg) Table 157. China Ceftazidime Sales Price by Application (2027-2032) & (US$/kg) Table 158. Asia Ceftazidime Revenue by Type (2021-2026) & (US$ Million) Table 159. Asia Ceftazidime Revenue by Type (2027-2032) & (US$ Million) Table 160. Asia Ceftazidime Sales by Type (2021-2026) & (tons) Table 161. Asia Ceftazidime Sales by Type (2027-2032) & (tons) Table 162. Asia Ceftazidime Sales Price by Type (2021-2026) & (US$/kg) Table 163. Asia Ceftazidime Sales Price by Type (2027-2032) & (US$/kg) Table 164. Asia Ceftazidime Revenue by Application (2021-2026) & (US$ Million) Table 165. Asia Ceftazidime Revenue by Application (2027-2032) & (US$ Million) Table 166. Asia Ceftazidime Sales by Application (2021-2026) & (tons) Table 167. Asia Ceftazidime Sales by Application (2027-2032) & (tons) Table 168. Asia Ceftazidime Sales Price by Application (2021-2026) & (US$/kg) Table 169. Asia Ceftazidime Sales Price by Application (2027-2032) & (US$/kg) Table 170. Asia Ceftazidime Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. Asia Ceftazidime Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. Asia Ceftazidime Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. Asia Ceftazidime Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 174. Asia Ceftazidime Sales by Country (2021-2026) & (tons) Table 175. Asia Ceftazidime Sales by Country (2027-2032) & (tons) Table 176. Asia Ceftazidime Sales Price by Country (2021-2026) & (US$/kg) Table 177. Asia Ceftazidime Sales Price by Country (2027-2032) & (US$/kg) Table 178. Japan Ceftazidime Revenue (2021-2032) & (US$ Million) Table 179. South Korea Ceftazidime Revenue (2021-2032) & (US$ Million) Table 180. India Ceftazidime Revenue (2021-2032) & (US$ Million) Table 181. Australia Ceftazidime Revenue (2021-2032) & (US$ Million) Table 182. Taiwan Ceftazidime Revenue (2021-2032) & (US$ Million) Table 183. Southeast Asia Ceftazidime Revenue (2021-2032) & (US$ Million) Table 184. SAMEA Ceftazidime Revenue by Type (2021-2026) & (US$ Million) Table 185. SAMEA Ceftazidime Revenue by Type (2027-2032) & (US$ Million) Table 186. SAMEA Ceftazidime Sales by Type (2021-2026) & (tons) Table 187. SAMEA Ceftazidime Sales by Type (2027-2032) & (tons) Table 188. SAMEA Ceftazidime Sales Price by Type (2021-2026) & (US$/kg) Table 189. SAMEA Ceftazidime Sales Price by Type (2027-2032) & (US$/kg) Table 190. SAMEA Ceftazidime Revenue by Application (2021-2026) & (US$ Million) Table 191. SAMEA Ceftazidime Revenue by Application (2027-2032) & (US$ Million) Table 192. SAMEA Ceftazidime Sales by Application (2021-2026) & (tons) Table 193. SAMEA Ceftazidime Sales by Application (2027-2032) & (tons) Table 194. SAMEA Ceftazidime Sales Price by Application (2021-2026) & (US$/kg) Table 195. SAMEA Ceftazidime Sales Price by Application (2027-2032) & (US$/kg) Table 196. SAMEA Ceftazidime Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 197. SAMEA Ceftazidime Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 198. SAMEA Ceftazidime Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 199. SAMEA Ceftazidime Sales by Country (2021 VS 2025 VS 2032) & (tons) Table 200. SAMEA Ceftazidime Sales by Country (2021-2026) & (tons) Table 201. SAMEA Ceftazidime Sales by Country (2027-2032) & (tons) Table 202. SAMEA Ceftazidime Sales Price by Country (2021-2026) & (US$/kg) Table 203. SAMEA Ceftazidime Sales Price by Country (2027-2032) & (US$/kg) Table 204. Brazil Ceftazidime Revenue (2021-2032) & (US$ Million) Table 205. Argentina Ceftazidime Revenue (2021-2032) & (US$ Million) Table 206. Chile Ceftazidime Revenue (2021-2032) & (US$ Million) Table 207. Colombia Ceftazidime Revenue (2021-2032) & (US$ Million) Table 208. Peru Ceftazidime Revenue (2021-2032) & (US$ Million) Table 209. Saudi Arabia Ceftazidime Revenue (2021-2032) & (US$ Million) Table 210. Israel Ceftazidime Revenue (2021-2032) & (US$ Million) Table 211. UAE Ceftazidime Revenue (2021-2032) & (US$ Million) Table 212. Turkey Ceftazidime Revenue (2021-2032) & (US$ Million) Table 213. Iran Ceftazidime Revenue (2021-2032) & (US$ Million) Table 214. Egypt Ceftazidime Revenue (2021-2032) & (US$ Million) Table 215. Key Raw Materials Table 216. Raw Materials Key Suppliers Table 217. Ceftazidime Distributors List Table 218. Ceftazidime Customers List Table 219. Research Programs/Design for This Report Table 220. Authors List of This Report Table 221. Secondary Sources Table 222. Primary Sources List of Figures Figure 1. Ceftazidime Image Figure 2. Global Ceftazidime Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ceftazidime Market Size Share 2021 VS 2025 VS 2032 Figure 4. Powder Injection Image Figure 5. Injection Image Figure 6. Global Ceftazidime Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Ceftazidime Market Size Share 2021 VS 2025 VS 2032 Figure 8. Respiratory Infections Image Figure 9. Urinary Infections Image Figure 10. Skin Infections Image Figure 11. Other Image Figure 12. Global Ceftazidime Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Ceftazidime Revenue (2021-2032) & (US$ Million) Figure 14. Global Ceftazidime Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Ceftazidime Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Ceftazidime Revenue Market Share by Region (2021-2032) Figure 17. Global Ceftazidime Sales (2021-2032) & (tons) Figure 18. Global Ceftazidime Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 19. Global Ceftazidime Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Ceftazidime Sales YoY (2021-2032) & (tons) Figure 21. Europe Ceftazidime Sales YoY (2021-2032) & (tons) Figure 22. China Ceftazidime Sales YoY (2021-2032) & (tons) Figure 23. Asia (Excluding China) Ceftazidime Sales YoY (2021-2032) & (tons) Figure 24. South America, Middle East and Africa Ceftazidime Sales YoY (2021-2032) & (tons) Figure 25. Global Ceftazidime Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Ceftazidime Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Ceftazidime Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Ceftazidime Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Ceftazidime Revenue Market Share by Type (2021-2032) Figure 31. Global Ceftazidime Sales by Type (2021 VS 2025 VS 2032) & (tons) Figure 32. Global Ceftazidime Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Ceftazidime Sales Market Share by Type (2021-2032) Figure 34. Global Ceftazidime Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Ceftazidime Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Ceftazidime Revenue Market Share by Application (2021-2032) Figure 37. Global Ceftazidime Sales by Application (2021 VS 2025 VS 2032) & (tons) Figure 38. Global Ceftazidime Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Ceftazidime Sales Market Share by Application (2021-2032) Figure 40. North America Ceftazidime Revenue Share by Type (2021-2032) Figure 41. North America Ceftazidime Sales Share by Type (2021-2032) Figure 42. North America Ceftazidime Revenue Share by Application (2021-2032) Figure 43. North America Ceftazidime Sales Share by Application (2021-2032) Figure 44. North America Ceftazidime Revenue Share by Country (2021-2032) Figure 45. North America Ceftazidime Sales Share by Country (2021-2032) Figure 46. Europe Ceftazidime Revenue Share by Type (2021-2032) Figure 47. Europe Ceftazidime Sales Share by Type (2021-2032) Figure 48. Europe Ceftazidime Revenue Share by Application (2021-2032) Figure 49. Europe Ceftazidime Sales Share by Application (2021-2032) Figure 50. Europe Ceftazidime Revenue Share by Country (2021-2032) Figure 51. Europe Ceftazidime Sales Share by Country (2021-2032) Figure 52. China Ceftazidime Revenue Share by Type (2021-2032) Figure 53. China Ceftazidime Sales Share by Type (2021-2032) Figure 54. China Ceftazidime Revenue Share by Application (2021-2032) Figure 55. China Ceftazidime Sales Share by Application (2021-2032) Figure 56. Asia Ceftazidime Revenue Share by Type (2021-2032) Figure 57. Asia Ceftazidime Sales Share by Type (2021-2032) Figure 58. Asia Ceftazidime Revenue Share by Application (2021-2032) Figure 59. Asia Ceftazidime Sales Share by Application (2021-2032) Figure 60. Asia Ceftazidime Revenue Share by Country (2021-2032) Figure 61. Asia Ceftazidime Sales Share by Country (2021-2032) Figure 62. SAMEA Ceftazidime Revenue Share by Type (2021-2032) Figure 63. SAMEA Ceftazidime Sales Share by Type (2021-2032) Figure 64. SAMEA Ceftazidime Revenue Share by Application (2021-2032) Figure 65. SAMEA Ceftazidime Sales Share by Application (2021-2032) Figure 66. SAMEA Ceftazidime Revenue Share by Country (2021-2032) Figure 67. SAMEA Ceftazidime Sales Share by Country (2021-2032) Figure 68. Ceftazidime Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Ceftazidime Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Powder Injection
  • Injection
Applications
  • Respiratory Infections
  • Urinary Infections
  • Skin Infections
  • Other
Companies covered
  • Fujian Fukang Pharmaceutical
  • NCPC
  • United Laboratories
  • Sinopharm Sandwich
  • Shanghai Pharmaceutical
  • Union Chempharma
  • Youcare Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Ceftazidime Market by Type
  3. 1.2.1 Global Ceftazidime Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Powder Injection
  5. 1.2.3 Injection
  6. 1.3 Ceftazidime Market by Application
  7. 1.3.1 Global Ceftazidime Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Respiratory Infections
  9. 1.3.3 Urinary Infections
  10. 1.3.4 Skin Infections
  11. 1.3.5 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Ceftazidime Market Dynamics
  1. 2.1 Ceftazidime Industry Trends
  2. 2.2 Ceftazidime Industry Drivers
  3. 2.3 Ceftazidime Industry Opportunities and Challenges
  4. 2.4 Ceftazidime Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Ceftazidime Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Ceftazidime Revenue by Region
  3. 3.2.1 Global Ceftazidime Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Ceftazidime Revenue by Region (2021-2026)
  5. 3.2.3 Global Ceftazidime Revenue by Region (2027-2032)
  6. 3.2.4 Global Ceftazidime Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Ceftazidime Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Ceftazidime Sales by Region
  9. 3.4.1 Global Ceftazidime Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Ceftazidime Sales by Region (2021-2026)
  11. 3.4.3 Global Ceftazidime Sales by Region (2027-2032)
  12. 3.4.4 Global Ceftazidime Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Ceftazidime Revenue by Manufacturers
  2. 4.1.1 Global Ceftazidime Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Ceftazidime Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Ceftazidime Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Ceftazidime Sales by Manufacturers
  6. 4.2.1 Global Ceftazidime Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Ceftazidime Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Ceftazidime Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Ceftazidime Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Ceftazidime Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Ceftazidime Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Ceftazidime Manufacturers, Product Type & Application
  13. 4.7 Global Ceftazidime Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Ceftazidime Market CR5 and HHI
  16. 4.8.2 2025 Ceftazidime Tier 1, Tier 2, and Tier 3
5 Ceftazidime Market by Type
  1. 5.1 Global Ceftazidime Revenue by Type
  2. 5.1.1 Global Ceftazidime Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Ceftazidime Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Ceftazidime Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Ceftazidime Sales by Type
  6. 5.2.1 Global Ceftazidime Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ceftazidime Sales by Type (2021-2032) & (tons)
  8. 5.2.3 Global Ceftazidime Sales Market Share by Type (2021-2032)
  9. 5.3 Global Ceftazidime Price by Type
6 Ceftazidime Market by Application
  1. 6.1 Global Ceftazidime Revenue by Application
  2. 6.1.1 Global Ceftazidime Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Ceftazidime Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Ceftazidime Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Ceftazidime Sales by Application
  6. 6.2.1 Global Ceftazidime Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Ceftazidime Sales by Application (2021-2032) & (tons)
  8. 6.2.3 Global Ceftazidime Sales Market Share by Application (2021-2032)
  9. 6.3 Global Ceftazidime Price by Application
7 Company Profiles
  1. 7.1 Fujian Fukang Pharmaceutical
  2. 7.1.1 Fujian Fukang Pharmaceutical Company Information
  3. 7.1.2 Fujian Fukang Pharmaceutical Business Overview
  4. 7.1.3 Fujian Fukang Pharmaceutical Ceftazidime Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Fujian Fukang Pharmaceutical Ceftazidime Product Portfolio
  6. 7.1.5 Fujian Fukang Pharmaceutical Recent Developments
  7. 7.2 NCPC
  8. 7.2.1 NCPC Company Information
  9. 7.2.2 NCPC Business Overview
  10. 7.2.3 NCPC Ceftazidime Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 NCPC Ceftazidime Product Portfolio
  12. 7.2.5 NCPC Recent Developments
  13. 7.3 United Laboratories
  14. 7.3.1 United Laboratories Company Information
  15. 7.3.2 United Laboratories Business Overview
  16. 7.3.3 United Laboratories Ceftazidime Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 United Laboratories Ceftazidime Product Portfolio
  18. 7.3.5 United Laboratories Recent Developments
  19. 7.4 Sinopharm Sandwich
  20. 7.4.1 Sinopharm Sandwich Company Information
  21. 7.4.2 Sinopharm Sandwich Business Overview
  22. 7.4.3 Sinopharm Sandwich Ceftazidime Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sinopharm Sandwich Ceftazidime Product Portfolio
  24. 7.4.5 Sinopharm Sandwich Recent Developments
  25. 7.5 Shanghai Pharmaceutical
  26. 7.5.1 Shanghai Pharmaceutical Company Information
  27. 7.5.2 Shanghai Pharmaceutical Business Overview
  28. 7.5.3 Shanghai Pharmaceutical Ceftazidime Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Shanghai Pharmaceutical Ceftazidime Product Portfolio
  30. 7.5.5 Shanghai Pharmaceutical Recent Developments
  31. 7.6 Union Chempharma
  32. 7.6.1 Union Chempharma Company Information
  33. 7.6.2 Union Chempharma Business Overview
  34. 7.6.3 Union Chempharma Ceftazidime Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Union Chempharma Ceftazidime Product Portfolio
  36. 7.6.5 Union Chempharma Recent Developments
  37. 7.7 Youcare Pharmaceutical
  38. 7.7.1 Youcare Pharmaceutical Company Information
  39. 7.7.2 Youcare Pharmaceutical Business Overview
  40. 7.7.3 Youcare Pharmaceutical Ceftazidime Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Youcare Pharmaceutical Ceftazidime Product Portfolio
  42. 7.7.5 Youcare Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Ceftazidime Market Size by Type
  2. 8.1.1 North America Ceftazidime Revenue by Type (2021-2032)
  3. 8.1.2 North America Ceftazidime Sales by Type (2021-2032)
  4. 8.1.3 North America Ceftazidime Price by Type (2021-2032)
  5. 8.2 North America Ceftazidime Market Size by Application
  6. 8.2.1 North America Ceftazidime Revenue by Application (2021-2032)
  7. 8.2.2 North America Ceftazidime Sales by Application (2021-2032)
  8. 8.2.3 North America Ceftazidime Price by Application (2021-2032)
  9. 8.3 North America Ceftazidime Market Size by Country
  10. 8.3.1 North America Ceftazidime Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Ceftazidime Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Ceftazidime Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Ceftazidime Market Size by Type
  2. 9.1.1 Europe Ceftazidime Revenue by Type (2021-2032)
  3. 9.1.2 Europe Ceftazidime Sales by Type (2021-2032)
  4. 9.1.3 Europe Ceftazidime Price by Type (2021-2032)
  5. 9.2 Europe Ceftazidime Market Size by Application
  6. 9.2.1 Europe Ceftazidime Revenue by Application (2021-2032)
  7. 9.2.2 Europe Ceftazidime Sales by Application (2021-2032)
  8. 9.2.3 Europe Ceftazidime Price by Application (2021-2032)
  9. 9.3 Europe Ceftazidime Market Size by Country
  10. 9.3.1 Europe Ceftazidime Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Ceftazidime Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Ceftazidime Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Ceftazidime Market Size by Type
  2. 10.1.1 China Ceftazidime Revenue by Type (2021-2032)
  3. 10.1.2 China Ceftazidime Sales by Type (2021-2032)
  4. 10.1.3 China Ceftazidime Price by Type (2021-2032)
  5. 10.2 China Ceftazidime Market Size by Application
  6. 10.2.1 China Ceftazidime Revenue by Application (2021-2032)
  7. 10.2.2 China Ceftazidime Sales by Application (2021-2032)
  8. 10.2.3 China Ceftazidime Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Ceftazidime Market Size by Type
  2. 11.1.1 Asia Ceftazidime Revenue by Type (2021-2032)
  3. 11.1.2 Asia Ceftazidime Sales by Type (2021-2032)
  4. 11.1.3 Asia Ceftazidime Price by Type (2021-2032)
  5. 11.2 Asia Ceftazidime Market Size by Application
  6. 11.2.1 Asia Ceftazidime Revenue by Application (2021-2032)
  7. 11.2.2 Asia Ceftazidime Sales by Application (2021-2032)
  8. 11.2.3 Asia Ceftazidime Price by Application (2021-2032)
  9. 11.3 Asia Ceftazidime Market Size by Country
  10. 11.3.1 Asia Ceftazidime Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Ceftazidime Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Ceftazidime Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Ceftazidime Market Size by Type
  2. 12.1.1 SAMEA Ceftazidime Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Ceftazidime Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Ceftazidime Price by Type (2021-2032)
  5. 12.2 SAMEA Ceftazidime Market Size by Application
  6. 12.2.1 SAMEA Ceftazidime Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Ceftazidime Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Ceftazidime Price by Application (2021-2032)
  9. 12.3 SAMEA Ceftazidime Market Size by Country
  10. 12.3.1 SAMEA Ceftazidime Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Ceftazidime Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Ceftazidime Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Ceftazidime Value Chain Analysis
  2. 13.1.1 Ceftazidime Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Ceftazidime Production Mode & Process
  6. 13.2 Ceftazidime Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Ceftazidime Distributors
  9. 13.2.3 Ceftazidime Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst